Patil, Maharashtra
Atul Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20120101030 | Caspofungin Composition - The present invention relates to a composition comprising caspofungin or a pharmaceutical acceptable salt thereof and succinate or lactate as a buffering agent. | 04-26-2012 |
Bhatu Tumba Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20080241949 | Process for preparing quetiapine fumarate - Provided is an improved synthesis of quetiapine and pharmaceutically acceptable salts. | 10-02-2008 |
Dipak Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20120303599 | DYNAMICALLY-CREATED LANDING WEBPAGE - Subject matter described herein is related to providing a landing webpage having dynamically generated content, which is deemed relevant to a search query submitted to a search engine. For example, a client device submits a search query to a search engine, which provides a list of webpage addresses. One of the webpage addresses, which includes the search query embedded therein, is selected on the client device, which sends a request to a landing server. The landing server parses the request to identify the search query and searches website-specific content in real time to dynamically generate website-specific content relevant to the search query. The dynamically generated content is included in the landing webpage, thereby providing a landing webpage having dynamically generated content. | 11-29-2012 |
Haresh Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20110087159 | Trocar Assembly - A trocar assembly including a sleeve assembly having a cannula connected to a housing and an obturator assembly including a handle connected to an obturator, wherein the obturator assembly is receivable in the sleeve assembly to define a gripping portion that includes the housing and the handle, the gripping portion having an axial length and a maximum width, and wherein a ratio of the axial length to the maximum width ranges from about 2.5 to about 3.5. | 04-14-2011 |
20110087168 | Trocar Assembly - A trocar assembly including a sleeve assembly defining a working channel extending axially therethrough and including an insufflation port in fluid communication with the working channel, and an insufflation valve assembly fluidly coupled to the insufflation port, the insufflation valve assembly including a valve member and a housing, wherein the valve member defines an inlet channel and is biased relative to the housing to a first position in which the inlet channel is in fluid communication with the working channel, and wherein the valve member is moveable relative to the housing from the first position to a second position in which the inlet channel is fluidly decoupled from the working channel. | 04-14-2011 |
20110087169 | Trocar Assembly - A trocar sleeve assembly including a cannula connected to a housing assembly to define a working channel, wherein the housing assembly includes a housing that defines an opening in fluid communication with the working channel, a sleeve slidably received over the housing to define an annular region between the sleeve and the housing, a first sealing member forming a first seal between the sleeve and the housing, and a second sealing member forming a second seal between the sleeve and the housing, the second sealing member being axially spaced from the first sealing member to define a chamber in the annular region, and an insufflation port in fluid communication with the chamber, wherein the sleeve is slidable relative to the housing between a first position, wherein the chamber is in fluid communication with the opening, and a second position, wherein the chamber is fluidly decoupled from the opening. | 04-14-2011 |
Harshad Ramdas Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20110046326 | CATALYST SYSTEM FOR POLYMERIZATION OF OLEFINS - The invention relates to a catalyst system for polymerization of olefins, the catalyst system comprising a titanium-containing procatalyst carrying internal electron donor(s), an organoaluminium cocatalyst and a mixture of external electron donors, the mixture comprising a carboxylic acid ester or derivatives thereof, an alkoxy silane and a nitrogen based compound. The invention also relates to a process for polymerization of olefin(s) and to the polyolefin synthesized by the process. | 02-24-2011 |
Kirti Gajanan Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100154376 | INHERENTLY COLOURED POLYESTER POLYMERS, FIBERS OR FILAMENTS AND PROCESS FOR PRODUCING THEM - Inherently colored polyester polymers with controlled branching include a chromophoric co-monomer in their backbone. The chromophoric co-monomer may be a carboxyl terminated chromophoric co-monomer. such as metallo-phthalocyanine tetracarboxylic acid. The inherently colored polyester polymer may be melt-spun into a filament or fiber. | 06-24-2010 |
Madhukar Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20110263713 | POLYMORPHS - The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions. Formula (I). | 10-27-2011 |
20110263718 | PROCESS FOR THE PREPARATION OF O-DESMETHYLVENLAFAXINE - The present invention provides a convenient and efficient process for the preparation of O-desmethylvenlafaxine (ODV) or a salt thereof, comprising the reaction of venlafaxine, or a salt thereof, with a thiourea or a mixture of thioureas. | 10-27-2011 |
20110269838 | NOVEL PROCESSES AND PURE POLYMORPHS - The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions. | 11-03-2011 |
20130143923 | CRYSTALLINE FORMS OF THALIDOMIDE AND PROCESSES FOR THEIR PREPARATION - The present invention related to crystalline forms of thalidomide having a high polymorphic purity and to processes for their preparation. The present invention also relates to pharmaceutical preparations comprising the crystalline forms for the treatment of patients suffering from autoimmune, inflammatory or angiogenic disorders. | 06-06-2013 |
Madhukar S. Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20110263712 | PROCESS FOR THE PREPARATION OF VORINOSTAT - The present invention relates to an improved process for the preparation of the active pharmaceutical ingredient vorinostat. In particular it relates to a process for preparing vorinostat substantially free from impurities, involving suberic acid, aniline and hydroxylamine as starting materials. | 10-27-2011 |
20150018424 | PROCESS FOR THE PREPARATION OF VORINOSTAT - The present invention relates to an improved process for the preparation of the active pharmaceutical ingredient vorinostat. In particular it relates to a process for preparing vorinostat substantially free from impurities. | 01-15-2015 |
Madhukar Shaligram Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20080214843 | Process for Manufacture of Simvastatin - An improved method for manufacture of simvastatin of formula (I) in high purity. The process for preparation of compound (I) comprises | 09-04-2008 |
20130203826 | Pure Intermediate - The present invention relates to an improved process for the preparation of Letrozole (I) and its synthetic intermediate 4-[(1-(1,2,4-triazoly)methyl]benzonitrile (III). In particular, it relates to a process to prepare Letrozole and its intermediate (III) substantially free from regioisomeric impurities. The present invention further relates to acid addition salts of 4-[(1-(1,2,4-triazoly)methyl]benzonitrile (III) such as the oxalate salt, and also to Letrozole (I), the intermediate (III) and salts thereof preparable by the processes of the present invention. | 08-08-2013 |
Mahendra Raghunath Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20080214843 | Process for Manufacture of Simvastatin - An improved method for manufacture of simvastatin of formula (I) in high purity. The process for preparation of compound (I) comprises | 09-04-2008 |
Mohan Narayan Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090176957 | Process for the preparation of nanoscale particles of elastic material - The present invention discloses a method for the manufacture of nanoscale particles of Styrene Butadiene Rubber (SBR). As SBR particles are elastic in nature, conventional methods of size reductions such as impacting, grinding are unable to achieve the final size. The present invention successfully achieves size reduction of the elastic material to nano scale by carefully controlled hydrodynamic cavitation techniques. | 07-09-2009 |
Nilesh Sudhir Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090181977 | Anhydrous Amorphous Imatinib Mesylate - Described is a highly stable amorphous form of imatinib mesylate having a water content of less than 0.5 percent by weight, based on the total weight of the amorphous imatinib mesylate, (anhydrous amorphous imatinib mesylate), a process for preparation thereof, and pharmaceutical compositions. | 07-16-2009 |
20090202647 | SOLID FORM OF RACEMIC ROTIGOTINE - Disclosed herein are solid state forms, amorphous and crystalline forms, of racemic rotigotine having high purity, adequate stability, good flowability and good dissolution properties, a process for preparation, and pharmaceutical compositions comprising amorphous racemic rotigotine. | 08-13-2009 |
20100330130 | SUBSTANTIALLY PURE IMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF - Provided herein are impurities of imatinib, N-(2-Methyl-5-methylamino-phenyl)-N-(4-pyridin-3-yl-pyrimidin-2-yl)-formamide (formamide impurity) and 4-[4-(Imidazole-1-carbonyl)-piperazin-1-ylmethyl]-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide (carbonylimidazole impurity), and processes for the preparation and isolation thereof. Provided further herein is a highly pure imatinib or a pharmaceutically acceptable salt thereof substantially free of formamide and carbonylimidazole impurities, processes for the preparation thereof, and pharmaceutical compositions comprising highly pure imatinib or a pharmaceutically acceptable salt thereof substantially free of impurities. Disclosed also herein is a process for preparing substantially pure α-form of imatinib mesylate. | 12-30-2010 |
20110117200 | RASAGILINE MESYLATE PARTICLES AND PROCESS FOR THE PREPARATION THEREOF - Provided herein is rasagiline mesylate having a 90 volume-percent of the particles (D | 05-19-2011 |
20110313176 | PROCESSES FOR PREPARING HIGHLY PURE ROTIGOTINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF - Provided herein are convenient, industrially advantageous and environmentally friendly processes for the preparation of (−)-(S)-5-hydroxy-2-[N-n-propyl-N-2-(2-thienyl)ethylamino]tetralin (rotigotine) or a pharmaceutically acceptable salt thereof. Provided further herein is a highly pure rotigotine or a pharmaceutically acceptable salt thereof substantially free of impurities, processes for the preparation thereof, and pharmaceutical compositions comprising highly pure rotigotine or a pharmaceutically acceptable salt thereof substantially free of impurities. | 12-22-2011 |
20120269871 | SOLID STATE FORMS OF RASAGILINE SALTS - Provided herein are novel crystalline forms of rasagiline salts, processes for their preparation, pharmaceutical compositions, and method of treating thereof. The rasagiline salts include a maleate salt, a mandelate salt, or a salicylate salt. | 10-25-2012 |
20130096347 | NOVEL PROCESS FOR PREPARING HIGHLY PURE TAPENTADOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF - Provided herein is a novel, commercially viable and industrially advantageous process for the preparation of 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol (Tapentadol), or a pharmaceutically acceptable salt thereof, and its intermediates, in high yield and purity. Provided also herein are novel solid state forms of tapentadol intermediates and processes for their preparation thereof. Provided further herein is a purification process for preparing highly pure tapentadol hydrochloride. | 04-18-2013 |
Prasad Chatursingh Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20140037394 | DIE HEAD RETAINING MECHANISM - A die head retaining mechanism for installing or removing a die head in a power drive for thread cutting operations is described. The mechanism comprises a cam and follower arrangement with a face gear having at least one locking jaw disposed in a slot provided on the face of the face gear oriented away from the housing. The mechanism also comprises a drive ring having a collection of cam profiles to control the movement of the locking jaws. The mechanism also comprises at least one compression spring disposed in corresponding groove(s) on the face gear. The compression spring is typically preloaded to keep the locking jaws in a locked position. The mechanism also comprises a bearing provided between the housing and the face gear. The bearing is locked in place by a retaining ring. A locking plate, spring washers, and screws are used to secure the assembly of the die head retaining mechanism on the power drive. | 02-06-2014 |
Pravin Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100291020 | NOVEL COMPOUNDS AS DIPEPTIDYL PEPTIDASE IV (DPP IV) INHIBITORS - The present invention is related to novel compounds of the general formula A, their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors, which are useful in the treatment or prevention of diseases particularly Type II diabetes, other complications related to diabetes and other pathogenic conditions in which DPP IV enzyme is involved. | 11-18-2010 |
Pravin Chaitram Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100004453 | PROCESS FOR PREPARATION OF METHYL-(+)-(S)-ALPHA-(2-CHLOROPHENYL)-6, 7-DIHYDROTHIENO[3,2-C]PYRIDINE-5 (4H) -ACETIC ACID METHYL ESTER OR SALTS THEREOF HAVING HIGHER CHIRAL PURITY AND PRODUCTS THEREOF - A process for preparation of Methyl-(+)-(S)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester or salts thereof [clopidogrel or salts thereof of Formula (I)] having higher chiral purity and products thereof is provided. A process for purification of the compound prepared is also provided to enhance its efficacy by enhancing its optical rotation and chiral purity. In Formula (I), R is selected from a group comprising alkyl, alkoxy, hydroxy, amine etc., and R | 01-07-2010 |
Prerana Maruti Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090221729 | WATER-SOLUBLE MACROMONOMERS CONTAINING TERMINAL UNSATURATION AND A PROCESS FOR THE PREPARATION THEREOF - This invention provides a water-soluble macromonomer having terminal unsaturation obtained by polymerization of monomers in the presence of inclusion complex of chain transfer agent in aqueous system. Hydrophobic chain transfer agent AMSD forms an inclusion complex with methylated cyclodextrin. The complexation enhances its solubility in water and enables the polymerization of water-soluble monomers in aqueous medium. After polymerization cyclodextrin is removed and the macromer with terminal unsaturation obtained can be used further for copolymerization with any vinyl monomer. | 09-03-2009 |
Rahul Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20140256602 | DRILLING FLUID THAT WHEN MIXED WITH A CEMENT COMPOSITION ENHANCES PHYSICAL PROPERTIES OF THE CEMENT COMPOSITION - According to an embodiment, a drilling fluid comprises: water and a set accelerator, wherein the drilling fluid has a 10 minute gel strength of less than 20 lb*ft/100 sq ft, wherein the drilling fluid has a density in the range of about 9 to about 14 pounds per gallon, wherein the drilling fluid remains pourable for at least 5 days, and wherein when at least one part of the drilling fluid mixes with three parts of a cement composition consisting of water and cement, the drilling fluid cement composition mixture develops a compressive strength of at least 1,200 psi. According to another embodiment, a method of using the drilling fluid comprises the steps of: introducing the drilling fluid into at least a portion of a subterranean formation, wherein at least a portion of the drilling fluid is capable of mixing with a cement composition. | 09-11-2014 |
Rahul Chandrakant Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20120152540 | METHODS FOR CEMENTING IN A SUBTERRANEAN FORMATION USING A CEMENT COMPOSITION CONTAINING CALCIUM SILICATE HYDRATE SEEDS - According to an embodiment, a method of cementing in a subterranean formation comprises: introducing a cement composition into the subterranean formation, wherein the cement composition comprises: cement; water; and calcium silicate hydrate (C—S—H) seeds, wherein a test cement composition consisting essentially of: the cement; the water; and the C—S—H seeds, and in the same proportions as in the cement composition, develops a compressive strength of at least 1,200 psi (8.3 MPa) when tested at 24 hours, a temperature of 60° F. (15.6° C.), and a pressure of 3,000 psi (20.7 MPa); and allowing the cement composition to set. According to another embodiment, the C—S—H seeds are mesoscopic particles, nanoparticles, or combinations thereof, and wherein the C—S—H seeds are in a concentration in the range of about 1% to about 5% by weight of the cement. | 06-21-2012 |
20120305248 | DRILLING FLUID THAT WHEN MIXED WITH A CEMENT COMPOSITION ENHANCES PHYSICAL PROPERTIES OF THE CEMENT COMPOSITION - According to an embodiment, a drilling fluid comprises: water and a set accelerator, wherein the drilling fluid has a 10 minute gel strength of less than 20 lb*ft/100 sq ft, wherein the drilling fluid has a density in the range of about 9 to about 14 pounds per gallon, wherein the drilling fluid remains pourable for at least 5 days, and wherein when at least one part of the drilling fluid mixes with three parts of a cement composition consisting of water and cement, the drilling fluid cement composition mixture develops a compressive strength of at least 1,200 psi. According to another embodiment, a method of using the drilling fluid comprises the steps of: introducing the drilling fluid into at least a portion of a subterranean formation, wherein at least a portion of the drilling fluid is capable of mixing with a cement composition. | 12-06-2012 |
Rahul Chandrakat Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20140090842 | Cement Compositions Comprising Deagglomerated Inorganic Nanotubes and Associated Methods - A variety of methods and compositions are disclosed, including, in one embodiment, a method of cementing comprising: providing an aqueous dispersion comprising deagglomerated inorganic nanotubes and water; preparing a cement composition using the aqueous dispersion; introducing the cement composition into a subterranean formation; and allowing the cement composition to set. Another method comprises a method of cementing comprising: providing an ultrasonicated aqueous dispersion comprising deagglomerated nanoparticles, a dispersing agent, and water; preparing a cement composition using the aqueous dispersion; introducing the cement composition into is subterranean formation; and allowing the cement composition to set. | 04-03-2014 |
Rajesh V. Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100269071 | INTEGRATING INFORMATION SOURCES - Disclosed is a method and system for integrating heterogeneous fragments of information from at least two collaboration channels, using one or more servers, each adapted to provide fragments from one collaboration channel; one or more adapters, each adapted to adapt a fragment provided by a corresponding server to an interface common to the collaboration channels; and a module adapted to: find a previously stored fragment related to a new adapted fragment, and create a link between the related fragment and the new fragment; and one or more repositories, each adapted to store an adapted fragment from a corresponding server. Other embodiments are also disclosed. | 10-21-2010 |
Sachin Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100288022 | NOVEL CHROMATOGRAPHY METHODS - The present invention relates to novel HPLC methods for the analysis of the API formoterol and related substances. In a first method the mobile phase comprises two or more liquids, and the relative concentration of the liquids is varied to a predetermined gradient. In a second method the mobile phase comprises a first liquid A comprising an aqueous solution of ammonium acetate and a second liquid B comprising a dipolar aprotic solvent. In a third method the mobile phase comprises a first liquid A comprising an aqueous solution of ammonium acetate with a concentration of 0.001 to 0.025M, and a second liquid B. The present invention also relates to a method for analysing a substance, comprising the detection and optional quantification of one or more specific impurities. | 11-18-2010 |
Sachin Sahebrao Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20110041589 | NEW HPCL METHOD - The present invention relates to new HPLC methods for the analysis of the drug substance clopidogrel and related substances. In a first method the mobile phase comprises two or more liquids, and the relative concentration of the liquids is varied to a predetermined gradient. In a second method the mobile phase comprises a polar protic organic solvent, and the stationary phase comprises a gel. The present invention also relates to a method for analysing a substance, comprising the detection and optional quantification of one or more specific impurities. | 02-24-2011 |
Samadhan Daulat Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20120071669 | PROCESS FOR PREPARATION OF ELETRIPTAN AND SALT THEREOF - The present invention relates to an improved process for the preparation of 3-(N-methyl-2(R)-pyrrolidinyl methyl)-5-[2-(phenyl sulfonyl)ethyl]-1H-indole or pharmaceutically acceptable salts thereof, particularly 3-(N-methyl-2(R)-pyrrolidinyl methyl)-5-[2-(phenyl sulfonyl)ethyl]-1H-indole hydrobromide (Eletriptan hydrobromide). The present invention further relates to novel polymorphs of 3-(N-methyl-2(R)-pyrrolidinyl methyl)-5-[2-(phenyl sulfonyl)ethenyl]-1H-indole hydrobromide and process for preparation thereof. | 03-22-2012 |
20120108828 | SYNTHESIS OF DRONEDARONE AND SALTS THEREOF - The present invention relates to a process for preparation of Dronedarone or pharmaceutically acceptable salts thereof. More particularly, the present invention provides a process for preparation of Dronedarone hydrochloride, without the isolation of Dronedarone base. | 05-03-2012 |
Sandeep Ramesh Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100017404 | Method and Apparatus to Elegantly and Automatically Track Emails and its Attachments for Enhanced User Convenience - An automated, embedded & intelligent E-mail Attachment Document manager automatically tracks email and their associated attachments and assists users in locating an email message (email-chain/thread) that is the original source from where the email attachment document. The present invention can perform the tracking action using the given name of the saved attachment file. | 01-21-2010 |
20100095127 | TUNABLE ENCRYPTION SYSTEM - A method, programmed medium and system are provided for enabling a user to choose a user-preferred encryption type from among a plurality of encryption types listed in a user's Kerberos configuration file. During the ticket granting process in a Kerberos system, a user is requested to select a preferred encryption type to be used in the Kerberos communication from among encryption types contained in the user's Kerberos configuration file. The user-selected encryption type is then implemented for use in encrypting a session ticket (as well as generating the session key of user requested encryption type) for use by the user machine in communicating securely with an Kerberized application server when being communicated by that particular user. Thus, the system allows different users to simultaneously communicate with the same Kerberized application server using a supported encryption type of the user's own choice. | 04-15-2010 |
Shantesh Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090298803 | PHARMACEUTICAL COMPOSITION COMPRISING FLUOCINONIDE - The present invention provides a composition, comprising fluocinonide in a vehicle comprising one or two penetration enhancers, solvents and emulsifiers wherein penetration enhancers are present in ratio of less than 0.90 to the total of the penetration enhancers, solvents and emulsifiers. | 12-03-2009 |
Sudhakar Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20110288298 | NOVEL POLYMORPH OF EMTRICITABINE AND A PROCESS FOR PREPARING OF THE SAME - A polymorph of emtricitabine, wherein said polymorph displays angular positions of characteristic peaks in powder X-ray diffraction pattern 13.61±0.2, 15.54±0.2, 19.49±0.2, 20.55±0.2, 25.89±0.2, 28.09±0.2 and 29.10±0.2. A pharmaceutical composition comprising a polymorph of emtricitabine displaying angular positions of characteristic peaks in powder X-ray diffraction pattern 13.61±0.2, 15.54±0.2, 19.49±0.2, 20.55±0.2, 25.89±0.2, 28.09±0.2 and 29.10±0.2. A process for the preparation of a polymorph of emtricitabine comprising the steps of (a) dissolving crude emtricitabine in polar organic solvent by heating at a temperature of at least 40° C. and not more than 150° C. to form a reaction mixture optionally decreasing the concentration of polar organic solvent in said reaction mixture; cooling the reaction mixture obtained in step (a); and separating the solid from the cooled reaction mixture resulted in step (b). | 11-24-2011 |
Swapnil Gopal Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20130081615 | REPLACEMENT LENS CARTRIDGE - Embodiments relate generally to a replaceable lens cartridge for use with a face mask, for example a respirator. The cartridge comprises a plurality of molded lenses, each lens sized to extend over one or more eyes of a wearer and typically having a curved shape and a plurality of catches; and a molded carrier mounting the lenses in stacked arrangement, the carrier having a first set of catches receiving the catches on one of the lenses. | 04-04-2013 |
20130174845 | SYSTEM AND METHOD OF OXYGEN DEFICIENCY WARNING IN A POWERED AIR PURIFYING RESPIRATOR - A powered air purifying respirator (PAPR). The PAPR comprises an electric motor mechanically coupled to a blower, an oxygen sensor, an alarm device, and a controller coupled to the oxygen sensor and to the electric motor, wherein the controller controls the electric motor, wherein the controller determines if the oxygen concentration is deficient, and wherein the controller commands the alarm device to present an indication when the oxygen concentration is deficient. | 07-11-2013 |
20130276217 | Adjustable Low Pressure Warning Device - A low pressure warning device that comprises a piston located inside the device, where the piston partitions the device into a first chamber communicating with a first opening and a second chamber communicating with a second opening, an adjustable stop, and a spring located inside the device and configured to bias the piston to a position based on a position of the adjustable stop and based on a pressure differential between the first opening and the second opening, wherein a low pressure differential warning state is associated with a position of the piston. | 10-24-2013 |
20140115864 | METHOD OF ASSEMBLY AND DISASSEMBLY OF ABRASIVE BLAST RESPIRATOR - Embodiments of methods of assembling an abrasive blast respirator are disclosed. The method may comprise removably attaching an exhalation valve into an exhalation valve port of a facepiece, removably installing the facepiece into a hood, removably attaching a filter to a first inhalation valve, where the first inhalation valve is coupled to the facepiece, and removably attaching a breathing hose to a second inhalation valve, where the second inhalation valve is coupled to the facepiece. | 05-01-2014 |
20140116429 | ABRASIVE BLAST RESPIRATOR - Embodiments relate to improvements for supplied-air abrasive blast respirators. Embodiments may comprise purified air via filters as a back-up air supply, with the filters typically operating automatically to provide purified air when the supplied air is compromised. Embodiments may locate elements outside of the hood to provide ready access for performing seal checks. Embodiments may incorporate noise reduction elements and/or lens protection elements as well. | 05-01-2014 |
20140116430 | METHOD OF DONNING AND TESTING ABRASIVE BLAST RESPIRATOR - Embodiments of methods of donning and/or testing an abrasive blast respirator may be described herein. The method may comprise one or more of the following, by way of example: placing head straps over a head of a user, wherein the head straps are coupled to an abrasive blast respirator, pulling a hood of the abrasive blast respirator over the head of the user, checking a seal of a facepiece of the abrasive blast respirator by blocking an opening of an exhalation valve coupled to the facepiece and exhaling by the user, where the opening of the exhalation valve is located on an outside of the abrasive blast respirator, and checking the seal of the facepiece by blocking one or more breathing filter coupled to the outside of the facepiece and inhaling by the user. | 05-01-2014 |
20140116445 | NOISE REDUCTION SYSTEM FOR SUPPLIED AIR RESPIRATOR - Embodiments relate generally to noise reduction techniques and systems for use with supplied air respirators. Typical embodiments may comprise porous elements located within a respirator system operable to alter the air flow pattern through the system and therefore reduce noise created in the system. These porous elements might be located within an inhalation valve, a breathing hose and/or a muffler block housing of a respirator system. | 05-01-2014 |
20140184407 | WEARABLE LOW PRESSURE WARNING DEVICE WITH AUDIO AND VISUAL INDICATION - Embodiments relate generally to low pressure warning devices which may be worn with encapsulated protective suits and hoods by a user and may provide audio and visual alerts. In an embodiment, a low pressure warning device may comprise an earpiece operable to be retained to the ear of a user, wherein the earpiece may comprise a control system operable to sense the pressure inside the encapsulated protective suit or hood and activate the audio and/or visual alerts when necessary. In an embodiment, the low pressure warning device may be equipped with short range wireless communication capabilities. | 07-03-2014 |
Vijaykumar J. Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090018123 | Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation - The present invention concerns recombinant DNA's comprising cDNA of genomic RNA of a Salmonidae alphavirus preceded by a spacer sequence, under the control of a suitable promoter. Said recombinant DNA's are useful for obtaining expression vectors, producing recombinant Salmonidae alphavirus, and for obtaining vaccines. | 01-15-2009 |
Vijaykumar Jadgishwar Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100120721 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES - The present invention relates to oxazolidinones of Formula I and pharmaceutically acceptable salts, pharmaceutically acceptable solvates or polymorphs thereof. The invention also relates to processes for the preparation of the compound of Formula I and pharmaceutically acceptable salts, pharmaceutically acceptable solvates or polymorphs thereof, and to pharmaceutical compositions containing the compounds of Formula I and pharmaceutically acceptable salts, pharmaceutically acceptable solvates or polymorphs thereof and to methods for treating or preventing microbial infections using the compounds of Formula I and pharmaceutically acceptable salts, pharmaceutically acceptable solvates or polymorphs thereof. | 05-13-2010 |
Vijaykumar Jagdishwar Patil, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100056581 | Substituted Piperidino Phenyloxazolidinones - The present invention relates to certain substituted piperidino phenyloxazolidinones. Specifically, the invention relates to geminally disubstituted piperidino phenyloxazolidinones having antimicrobial activity with improved pharmacokinetic profile. The invention also relates to processes for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods for treating or preventing microbial infections using the compounds of the present invention. | 03-04-2010 |